Cargando…
The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are known to increase the risk of stroke. OBJECTIVES: We set out to examine the risk of stroke by kidney function and albuminuria in patients with and without AF. DESIGN: Retrospective cohort study. SETTINGS: Ontario, Canada. PART...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893926/ https://www.ncbi.nlm.nih.gov/pubmed/31839975 http://dx.doi.org/10.1177/2054358119892372 |
_version_ | 1783476300934021120 |
---|---|
author | Mace-Brickman, Trevor Eddeen, Anan Bader Carrero, Juan-Jesus Mark, Patrick B. Molnar, Amber O. Lam, Ngan N. Zimmerman, Deborah Harel, Ziv Sood, Manish M. |
author_facet | Mace-Brickman, Trevor Eddeen, Anan Bader Carrero, Juan-Jesus Mark, Patrick B. Molnar, Amber O. Lam, Ngan N. Zimmerman, Deborah Harel, Ziv Sood, Manish M. |
author_sort | Mace-Brickman, Trevor |
collection | PubMed |
description | BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are known to increase the risk of stroke. OBJECTIVES: We set out to examine the risk of stroke by kidney function and albuminuria in patients with and without AF. DESIGN: Retrospective cohort study. SETTINGS: Ontario, Canada. PARTICIPANTS: A total of 736 666 individuals (>40 years) from 2002 to 2015. MEASUREMENTS: New-onset AF, albumin-to-creatinine ratio (ACR), and an estimated glomerular filtration rate (eGFR). METHODS: A total of 39 120 matched patients were examined for the risk of ischemic, hemorrhagic, or any stroke event, accounting for the competing risk of all-cause mortality. Interaction terms for combinations of ACR/eGFR and the outcome of stroke with and without AF were examined. RESULTS: In a total of 4086 (5.2%) strokes (86% ischemic), the presence of AF was associated with a 2-fold higher risk for any stroke event and its subtypes of ischemic and hemorrhagic stroke. Across eGFR levels, the risk of stroke was 2-fold higher with the presence of AF except for low levels of eGFR (eGFR < 30 mL/min/1.73 m(2), hazard ratio [HR]: 1.38, 95% confidence interval [CI]: 0.99-1.92). Similarly across ACR levels, the risk of stroke was 2-fold higher except for high levels of albuminuria (ACR > 30 mg/g, HR: 1.61, 95% CI: 1.31-1.99). The adjusted risk of stroke with AF differed by combinations of ACR and eGFR categories (interaction P value = .04) compared with those without AF. Both stroke types were more common in patients with AF, and ischemic stroke rates differed significantly by eGFR and ACR categories. LIMITATIONS: Medication information was not included. CONCLUSIONS: Patients with CKD and AF are at a high risk of total, ischemic, and hemorrhagic strokes; the risk is highest with lower eGFR and higher ACR and differs based on eGFR and the degree of ACR. |
format | Online Article Text |
id | pubmed-6893926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-68939262019-12-13 The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease Mace-Brickman, Trevor Eddeen, Anan Bader Carrero, Juan-Jesus Mark, Patrick B. Molnar, Amber O. Lam, Ngan N. Zimmerman, Deborah Harel, Ziv Sood, Manish M. Can J Kidney Health Dis Original Clinical Research BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are known to increase the risk of stroke. OBJECTIVES: We set out to examine the risk of stroke by kidney function and albuminuria in patients with and without AF. DESIGN: Retrospective cohort study. SETTINGS: Ontario, Canada. PARTICIPANTS: A total of 736 666 individuals (>40 years) from 2002 to 2015. MEASUREMENTS: New-onset AF, albumin-to-creatinine ratio (ACR), and an estimated glomerular filtration rate (eGFR). METHODS: A total of 39 120 matched patients were examined for the risk of ischemic, hemorrhagic, or any stroke event, accounting for the competing risk of all-cause mortality. Interaction terms for combinations of ACR/eGFR and the outcome of stroke with and without AF were examined. RESULTS: In a total of 4086 (5.2%) strokes (86% ischemic), the presence of AF was associated with a 2-fold higher risk for any stroke event and its subtypes of ischemic and hemorrhagic stroke. Across eGFR levels, the risk of stroke was 2-fold higher with the presence of AF except for low levels of eGFR (eGFR < 30 mL/min/1.73 m(2), hazard ratio [HR]: 1.38, 95% confidence interval [CI]: 0.99-1.92). Similarly across ACR levels, the risk of stroke was 2-fold higher except for high levels of albuminuria (ACR > 30 mg/g, HR: 1.61, 95% CI: 1.31-1.99). The adjusted risk of stroke with AF differed by combinations of ACR and eGFR categories (interaction P value = .04) compared with those without AF. Both stroke types were more common in patients with AF, and ischemic stroke rates differed significantly by eGFR and ACR categories. LIMITATIONS: Medication information was not included. CONCLUSIONS: Patients with CKD and AF are at a high risk of total, ischemic, and hemorrhagic strokes; the risk is highest with lower eGFR and higher ACR and differs based on eGFR and the degree of ACR. SAGE Publications 2019-12-04 /pmc/articles/PMC6893926/ /pubmed/31839975 http://dx.doi.org/10.1177/2054358119892372 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Clinical Research Mace-Brickman, Trevor Eddeen, Anan Bader Carrero, Juan-Jesus Mark, Patrick B. Molnar, Amber O. Lam, Ngan N. Zimmerman, Deborah Harel, Ziv Sood, Manish M. The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease |
title | The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease |
title_full | The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease |
title_fullStr | The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease |
title_full_unstemmed | The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease |
title_short | The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease |
title_sort | risk of stroke and stroke type in patients with atrial fibrillation and chronic kidney disease |
topic | Original Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893926/ https://www.ncbi.nlm.nih.gov/pubmed/31839975 http://dx.doi.org/10.1177/2054358119892372 |
work_keys_str_mv | AT macebrickmantrevor theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT eddeenananbader theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT carrerojuanjesus theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT markpatrickb theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT molnarambero theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT lamngann theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT zimmermandeborah theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT harelziv theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT soodmanishm theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT macebrickmantrevor riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT eddeenananbader riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT carrerojuanjesus riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT markpatrickb riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT molnarambero riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT lamngann riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT zimmermandeborah riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT harelziv riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease AT soodmanishm riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease |